The largest observational study of COVID-19 — including almost 6,000 individuals — has shown that metformin use was associated with decreased mortality in women, but
The Parsemus Foundation has provided seed funding to initiate research on use of the common diabetes medication metformin for prevention and treatment of COVID-19. The
One of the risk factors for severe illness from COVID-19 is diabetes. While scientists aren’t sure why diabetes leads to poorer outcomes for COVID-19 patients,
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:
